GRLS data [Power / Sample Size]

posted by mittyri  – Russia, 2019-03-14 00:06 (2306 d 15:55 ago) – Posting: # 20032
Views: 4,881

Hi Elena,

you are right, there's no open data regarding Chloropyramine.
By the way GRLS says that at least 2 companies performed BEQ studies. The sample size was (unfortunately we don't know exactly what 'the number of patients' means - sample size? number of subjects intended to be screened?) not more than 22 and 40. I would say this is not HVD.

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,677 registered users;
36 visitors (0 registered, 36 guests [including 13 identified bots]).
Forum time: 17:01 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5